Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Ann Vasc Surg ; 44: 419.e1-419.e12, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28642109

RESUMEN

BACKGROUND: There is no international consensus regarding the optimum management of infected aortae (mycotic aneurysms, infected aortic grafts). Neoaortoiliac reconstruction has advantages over extra-anatomical bypass grafting; however, the use of autologous vein is associated with venous hypertension and compartment syndrome, alternatively cadaveric homografts are associated with high rates of perianastomotic hemorrhage, limb occlusion, and pseudoaneurysm. Arterial repair using xenoprosthetic patches is associated with lower infection rates compared to the use of prosthetic material. The aim of this case series and literature review is to report the use of xenoprosthetic bovine biomaterial for neoaortic repair of mycotic aneurysmal disease and infected aortic grafts. METHODS: Patients with evidence of infected aortic grafts or mycotic aneurysms who were suitable for open aortic surgery were included. Following removal of the graft/excision of the aneurysmal sac, a 10 × 16 cm XenoSure Biologic Surgical Patch (LeMaitre, Germany) was rolled into a tube, or bifurcated tube graft, and secured with prolene sutures. Proximal and distal anastomoses were conducted as per standard aortic anastomoses. Patients were continued on long-term antibiotics and surveyed with computerized tomography at 1, 3, 6, and 12 months. RESULTS: Six patients underwent bovine aortic repair between 2013 and 2015: an infected Dacron aortobi-iliac graft causing iliac pseudoaneurysm, an infected Dacron aortic graft from open repair later relined with endovascular stent graft, a mycotic iliac aneurysm, and 3 mycotic aortic aneurysms. All were treated with bovine reconstructed aortic grafts or patches. Patients had a median age of 69.5 years (range 67-75), with perioperative and 30-day mortality of 0%. Median follow-up was 13 months (range 2-23). Postoperative contrast-enhanced computed tomography revealed no evidence of infection at the operative site in all patients. Freedom from reinfection and reintervention was 100%. CONCLUSIONS: Xenoprosthetic (bovine) neoaortic grafts are an alternative method to treat infected aortae with excellent short-term freedom from infection and reintervention. Optimum duration of postoperative antibiotic therapy remains undetermined. Further cases and longer follow-up are required to determine the true efficacy of this technique.


Asunto(s)
Aneurisma Infectado/cirugía , Aneurisma de la Aorta/cirugía , Implantación de Prótesis Vascular/instrumentación , Prótesis Vascular , Infecciones Relacionadas con Prótesis/cirugía , Anciano , Aneurisma Infectado/diagnóstico por imagen , Aneurisma Infectado/microbiología , Animales , Antibacterianos/administración & dosificación , Aneurisma de la Aorta/diagnóstico por imagen , Aneurisma de la Aorta/microbiología , Aortografía/métodos , Prótesis Vascular/efectos adversos , Implantación de Prótesis Vascular/efectos adversos , Bovinos , Angiografía por Tomografía Computarizada , Remoción de Dispositivos , Xenoinjertos , Humanos , Tereftalatos Polietilenos , Diseño de Prótesis , Infecciones Relacionadas con Prótesis/diagnóstico por imagen , Infecciones Relacionadas con Prótesis/microbiología , Técnicas de Sutura , Resultado del Tratamiento
2.
JACC Cardiovasc Imaging ; 13(4): 1008-1017, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31202739

RESUMEN

OBJECTIVES: This study determined whether in vivo positron emission tomography (PET) of arterial inflammation (18F-fluorodeoxyglucose [18F-FDG]) or microcalcification (18F-sodium fluoride [18F-NaF]) could predict restenosis following PTA. BACKGROUND: Restenosis following lower limb percutaneous transluminal angioplasty (PTA) is common, unpredictable, and challenging to treat. Currently, it is impossible to predict which patient will suffer from restenosis following angioplasty. METHODS: In this prospective observational cohort study, 50 patients with symptomatic peripheral arterial disease underwent 18F-FDG and 18F-NaF PET/computed tomography (CT) imaging of the superficial femoral artery before and 6 weeks after angioplasty. The primary outcome was arterial restenosis at 12 months. RESULTS: Forty subjects completed the study protocol with 14 patients (35%) reaching the primary outcome of restenosis. The baseline activities of femoral arterial inflammation (18F-FDG tissue-to-background ratio [TBR] 2.43 [interquartile range (IQR): 2.29 to 2.61] vs. 1.63 [IQR: 1.52 to 1.78]; p < 0.001) and microcalcification (18F-NaF TBR 2.61 [IQR: 2.50 to 2.77] vs. 1.69 [IQR: 1.54 to 1.77]; p < 0.001) were higher in patients who developed restenosis. The predictive value of both 18F-FDG (cut-off TBRmax value of 1.98) and 18F-NaF (cut-off TBRmax value of 2.11) uptake demonstrated excellent discrimination in predicting 1-year restenosis (Kaplan Meier estimator, log-rank p < 0.001). CONCLUSIONS: Baseline and persistent femoral arterial inflammation and micro-calcification are associated with restenosis following lower limb PTA. For the first time, we describe a method of identifying complex metabolically active plaques and patients at risk of restenosis that has the potential to select patients for intervention and to serve as a biomarker to test novel interventions to prevent restenosis.


Asunto(s)
Angioplastia de Balón/efectos adversos , Arteria Femoral/diagnóstico por imagen , Enfermedad Arterial Periférica/diagnóstico por imagen , Enfermedad Arterial Periférica/terapia , Tomografía de Emisión de Positrones , Anciano , Anciano de 80 o más Años , Femenino , Arteria Femoral/fisiopatología , Fluorodesoxiglucosa F18/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Enfermedad Arterial Periférica/fisiopatología , Placa Aterosclerótica , Valor Predictivo de las Pruebas , Estudios Prospectivos , Radiofármacos/administración & dosificación , Recurrencia , Factores de Riesgo , Fluoruro de Sodio/administración & dosificación , Factores de Tiempo , Resultado del Tratamiento
3.
Surg Laparosc Endosc Percutan Tech ; 20(4): 213-9, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20729687

RESUMEN

BACKGROUND: The long-term complications after implantation of a prosthetic mesh in inguinal hernia repair remain a concern. Recent development of new mesh materials has resulted in meshes with lower weight (LW) and with better biocompatibility. AIM: To compare hernia repair with partially or completely absorbable meshes with conventional nonabsorbable mesh repair. METHODS: A literature search was performed using Medline, Embase, and Cochrane databases to identify relevant randomized controlled trials and comparative studies. The primary outcomes were: hospital stay, time taken to return to work, seroma, hematoma, wound infection, groin pain, chronic pain, foreign body sensation, recurrence, and testicular atrophy. RESULTS: Nine trials containing 3133 inguinal hernia repairs were analyzed. There was no significant difference between the groups for hospital stay, time taken to return to work, hematoma, wound infection, testicular atrophy, or recurrence. The incidence of seroma was greater after LW nonabsorbable mesh repair compared with high weight nonabsorbable mesh repair [pooled odds ratio 52.88, 95% confidence interval (CI)=3.11-898.19, P=0.006]. The use of LW meshes was associated with a significant reduction in prolonged pain (pooled effect size 0.13, 95% CI= -0.33-0.59, P=0.58) and foreign body sensation (pooled odds ratio 0.5, 95% CI=0.2-1.21, P=0.12). These effects were seen with both LW nonabsorbable and absorbable meshes compared with high weight nonabsorbable meshes. CONCLUSIONS: Absorbable and nonabsorbable mesh repair of inguinal hernias do not seem to afford any significant benefit over each other. It is the weight of meshes that seems to have significant influence on long-term complications after mesh repair.


Asunto(s)
Implantes Absorbibles , Hernia Inguinal/cirugía , Mallas Quirúrgicas , Materiales Biocompatibles , Diseño de Equipo , Humanos , Medición de Riesgo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA